Table 1.
Reference | Population | Criteria | Prevalence (%) | Association |
---|---|---|---|---|
Souza et al. [17] | NDD |
|
|
ADL, gait speed, functional capacity, higher BMI |
Zhou et al. [18] | NDD CKD (Stages 3–5) |
|
|
Measured GFR, functional reach, Berg balance score. |
Pereira et al. [10] | NDD CKD (3–5) |
|
|
Mortality HR (association between mortality and sarcopenia according to BIA significant after multivariate adjustment) |
Lamarca et al. [19] | HD CKD |
|
|
|
Kittiskulnam et al. [20] | HD CKD |
|
|
Gait speed (Associations between data and mortality presented in another paper [21]. Significantly higher mortality rate in sarcopenic patients, according to low MM, but not in adjusted models) |
Gracia-Iguacel et al. [22] | HD CKD |
|
|
No association between PEW and mortality but loss of MM associated with increased mortality |
Carrero et al. [24] | HD | SGA | 39 | Mortality risk |
Kittiskulnam et al. [21] | HD | HGS <26/16 kg men/women | 29.9 | Low HGS and slow gait speed associated with mortality risk |
Chang et al. [25] | NDD CKD | HGS, SGA, BIA, MAMC, MAMA, MAC, SKF | N/A | Only HGS was significantly associated with composite endpoints of non-dialysis mortality and ESRD |
Isoyama et al. [26] | Dialysis CKD |
|
|
|
Wang et al. [27] | NDD CKD | LTI <10% reference value | 12.2% | Serum albumin, eGFR, age, IL-6, CVD |
ASMI, Appendicular Skeletal Muscle Index; BIA, bioelectrical impedance analysis; BSA, body surface area; CC, calf circumference; DEXA, dual-energy X-ray absorptiometry; SKF, skinfold thickness; HGS, handgrip strength; LTI, Lean Tissue Index.; MAC, mid-arm circumference; MAMA, mid-arm muscle area; MAMC, mid-arm muscle circumference; NDD, non-dialysis dependent; SGA, subjective global assessment; SM, skeletal muscle.